Abstract
Inflammatory bowel disease, ulcerative rectocolitis and Crohn’s disease are a major public health problem. The incidence of ulcerative rectocolitis (UC), which has remained stable since the early eighties, is around 10 per 100 000 inhabitants [1]. Crohn’s disease (CD) appears to be on the increase, with a global incidence of 5.6 / 100 000 [1]. These diseases are associated with a risk of digestive cancer, which justifies regular endoscopic surveillance. Unfortunately, there is no properly-defined code for such surveillance, which is performed on an empirical basis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
